Fuller H B vs Quaker Chemical
FUL and KWR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FUL and KWR compare
Fuller H B and Quaker Chemical are about the same size, with market caps of $2.7B and $2.7B.
On earnings, Fuller H B is cheaper: it trades at 13.7× trailing earnings, against 27.7× for Quaker Chemical.
Quaker Chemical grew revenue faster over the last twelve months (8.7% versus 1.5% for Fuller H B).
Fuller H B keeps more of each dollar of sales as profit, with a net margin of 5.6% compared with 4.8% at Quaker Chemical.
Both pay dividends: Fuller H B yields 2.0% and Quaker Chemical 1.3%.
Fuller H B scores higher on the StockData Score (18 against 9 for Quaker Chemical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FUL | KWR |
|---|---|---|
| Size and price | ||
| Market cap | $2.7B | $2.7B |
| Share price | $49.29 | $155.43 |
| Change, 1 year | −14.8% | 13.2% |
| Change, 5 years | −35.6% | −37.2% |
| Beta (5Y) | 0.95 | 1.44 |
| Employees | 7,100 | 4,700 |
| StockData Score | ||
| Total score | 18 (better) | 9 |
| Valuation score | 6 (better) | 2 |
| Growth score | 3 (better) | 0 |
| Performance score | 3 (better) | 1 |
| Health score | 2 | 2 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 13.7× (better) | 27.7× |
| P/S | 0.7× (better) | 1.3× |
| P/B | 1.2× (better) | 1.9× |
| EV/EBITDA | 7.9× (better) | 15.2× |
| P/FCF | 26.5× (better) | 67.8× |
| FCF yield | 3.8% (better) | 1.5% |
| Fair value | $102.06 | $141.78 |
| Margin of safety | 51.7% (better) | −9.6% |
| Growth | ||
| Revenue growth (TTM) | 1.5% | 8.7% (better) |
| Revenue growth, 5Y average | 4.5% | 5.9% (better) |
| Net income growth (TTM) | 72.2% | – |
| EPS growth (TTM) | 71.8% | – |
| EPS growth, 5Y average | 3.1% | – |
| Profitability | ||
| Gross margin | 32.3% | 35.8% (better) |
| Operating margin | – | 7.6% |
| Net margin | 5.6% (better) | 4.8% |
| FCF margin | 2.8% (better) | 1.9% |
| Return on equity | 9.6% (better) | 7.0% |
| Return on invested capital | – | 5.2% |
| Financial health | ||
| Debt / equity | 0.95 | 0.63 (better) |
| Net debt / EBITDA | 3.35 | 3.23 (better) |
| Interest coverage | – | 3.8× |
| Current ratio | 1.82 | 2.47 (better) |
| Altman Z-score | 1.85 | 2.51 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.0% (better) | 1.3% |
| Payout ratio | 26.2% | 36.2% |
| Years of dividend growth | 16 | 16 |
| Dividend growth, 5Y average | 7.4% (better) | 5.0% |
| Buyback yield | 1.8% | – |
| Shareholder yield | 3.8% (better) | 1.3% |
| Ownership | ||
| Held by institutions | 104% | 91.9% |
| Held by insiders | 0.65% | 22.4% |
| Insider net buying, 12 months | $853K (better) | −$208K |
| Short interest, % of float | 4.1% | 12.3% |
Go deeper
- FUL stock overview
- FUL income statement
- FUL valuation and score
- KWR stock overview
- KWR income statement
- KWR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.